Celldex Therapeutics, Inc. (NASDAQ: CLDX) seems to be poised for a price surge as per its latest charts. The company engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer.
#1 Downtrend Channel: As you can see from the daily chart, the stock has been trading within a downtrend channel for the past few months. This is marked in the daily chart in purple color. Currently, the stock is moving higher from the lower rail of the downtrend channel with high volume. Once the stock breaks out from a downtrend channel, it has the potential to move further up.
#2 MACD Above Signal Line: In the daily chart, the MACD line (light blue color) is currently above the MACD signal line (orange color) which is typically considered bullish.
#3 Bullish ADX: The ADX indicator shows that the +DI line is currently above the –DI line and the ADX line has started to move up from below –DI and +DI lines. This indicates possible bullishness.
#4 Bullish RSI: In the daily chart, the RSI is currently above 50. This is a possible bullish sign.
#5 Flag Pattern: The weekly chart shows that the stock was in a strong uptrend after which it started consolidating and was in a narrow range. This is a classic flag pattern, which is a continuation pattern. The flag pattern is marked in orange color in the chart. Whenever a stock breaks out of the flag pattern, it typically continues its previous trend which is an uptrend in this case.
#6 %K above %D: The %K (blue) line of stochastic has currently crossed above the %D (Orange) line in the weekly chart, and is also moving higher from oversold levels. This is a possible bullish indication.
#7 Bullish RSI: In the weekly chart, the RSI is currently moving higher from oversold levels. This is a possible bullish sign.
Recommended Trade (based on the charts)
Buy Levels: If you want to get in on this trade, you can purchase the shares of CLDX above the price of around $29.40.
TP: Our target prices are $35 and $39 in the next 3-6 months.
SL: To limit risk, place stop-loss at $26.10. Note that the stop-loss is on a closing basis.
Our target potential upside is 19% to 33% in the next 3 to 6 months.
For a risk of $3.30, our target rewards are $5.60 and $9.60. This is a nearly 1:2 and 1:3 risk-reward trade.
In other words, this trade offers nearly 2x to 3x more potential upside than downside.
Risks to Consider
The stock may reverse its overall trend if it breaks down from the trend channel with a high volume. The sell-off of the stock could also be triggered in case of any negative news, overall weakness in the market, or any regulatory changes in the sector.
— TaraV-Tolling Is Set to Be More Popular than Electric and Self-Driving Cars COMBINED [sponsor]
You can be among the first early adopters of this new technology... and get in on the ground floor of ONE company trading for just $10 right now. Matt McCall breaks the full story and details his No. 1 recommendation, right here.